HNWAG
RVMD icon

High Net Worth Advisory Group’s Revolution Medicines RVMD Stock Holding History

High Net Worth Advisory Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$375K Buy
+2,000
New +$292K 0.08% 185
2023
Q1 		– Sell
-2,000
Closed -$47.6K – 498
2022
Q4 		$47.6K Hold
2,000
– – 0.02% 335
2022
Q3 		$39K Buy
+2,000
New +$44K 0.02% 365

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

High Net Worth Advisory Group's RVMD Position: Q2 2026 in Review

High Net Worth Advisory Group opened a new position in Revolution Medicines (RVMD) in Q2 2026: 2,000 shares worth $375K. The stake represents 0.08% of the portfolio and ranks #185 among its holdings. This is a return to the name: High Net Worth Advisory Group previously reported a position in RVMD as recently as Q4 2022.

High Net Worth Advisory Group first reported a position in RVMD in Q3 2022 and has held it in 3 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • High Net Worth Advisory Group held 2,000 shares of Revolution Medicines worth $375K as of Q2 2026.
  • Revolution Medicines was a new High Net Worth Advisory Group position in Q2 2026.
  • Revolution Medicines made up 0.08% of High Net Worth Advisory Group's portfolio in Q2 2026, its #185 holding.
  • High Net Worth Advisory Group first reported a position in Revolution Medicines in Q3 2022 and has held it in 3 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on High Net Worth Advisory Group's 13F filing for Q2 2026, filed 29 Jul 2026.